Celcuity receives US patent for its lead drug candidate, gedatolisib; getting exclusivity up to 2042: Minneapolis Thursday, July 17, 2025, 16:00 Hrs [IST] Minneapolis-headquartere ...

An item in Republicans’ sweeping policy and tax bill intended to block Medicaid dollars from flowing to Planned Parenthood, the nation’s biggest abortion provider, is also hitting a major medical ...

A study published by Caris showed that certain tumor types had very low or no HER2 overexpression, which has implications for biomarker testing strategies.

Zenith Epigenetics' ZEN-3694 gains FDA fast track designation, offering hope for patients with aggressive NUT carcinoma ...

Understanding actionable mutations and educating patients on the safety profiles of targeted therapies are essential for the ...

Dr. Olalekan O. Oluwole explained how CAR T is used to treat high-risk blood cancers and highlighted the potential of ...

An item in Republicans' sweeping policy and tax bill intended to block Medicaid dollars from flowing to Planned Parenthood, the nation's biggest abortion provider, is also hitting a major medical ...

Carotuximab plus Erleada proved safe in the first 10 patients with metastatic castration-resistant prostate cancer dosed on ...

For the past 20 years, many of the dramatic improvements in cancer outcomes can be attributed to personalized cancer ...

Previous treatment for depression, high BMI and inflammation levels, and early signs of functional impairment may be risk factors for physical function decline in HIV.

The response rate to Amtagvi was higher in patients who had received two or fewer therapies than in those with more heavily ...

Panelists discuss the growing promise of GPRC5D-targeted therapy in relapsed/refractory multiple myeloma, highlighting MonumenTAL-1 trial data showing encouraging responses in heavily pretreated ...